Literature DB >> 8738260

Deferoxamine improves spatial memory performance following experimental brain injury in rats.

D A Long1, K Ghosh, A N Moore, C E Dixon, P K Dash.   

Abstract

Traumatic brain injury (TBI) causes impairments of both motor and spatial memory performances. Research is only beginning to reveal the biochemical mechanism(s) underlying these deficits. It has been postulated that reactive oxygen species such as the superoxide and hydroxyl radicals, as well as the peroxynitrite anion, are generated by injury and may play a critical role in the observed memory deficits. The highly reactive hydroxyl radical, which is thought to contribute to neuronal toxicity, can be generated by an iron-catalyzed reaction. The source of this iron (or iron-bound proteins) could be a compromise of the blood-brain barrier, which can occur following TBI. In this report, we investigate the ability of deferoxamine, a scavenger of free iron, the hydroxyl radical and the peroxynitrite anion, to facilitate behavioral recovery following a controlled cortical impact of rats. Intraperitoneal administration of this drug prior to the injury did not affect the rate of recovery from motor deficits in comparison to vehicle (saline)-injected animals. However, deferoxamine-treated animals showed significant improvement in spatial memory performance in a Morris water maze task. Volumetric analysis of cortical tissue loss showed no significant differences between vehicle- and drug-injected animals. Similarly, histological examination of the hippocampus did not reveal any gross differences between the two groups. These results indicate that deferoxamine improves spatial memory performance, possibly through protection from neuronal dysfunction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738260     DOI: 10.1016/0006-8993(95)01500-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

1.  Brain iron quantification in mild traumatic brain injury: a magnetic field correlation study.

Authors:  E Raz; J H Jensen; Y Ge; J S Babb; L Miles; J Reaume; R I Grossman; M Inglese
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-01       Impact factor: 3.825

Review 2.  Antioxidant therapies for traumatic brain injury.

Authors:  Edward D Hall; Radhika A Vaishnav; Ayman G Mustafa
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

3.  Deferoxamine attenuates acute hydrocephalus after traumatic brain injury in rats.

Authors:  Jinbing Zhao; Zhi Chen; Guohua Xi; Richard F Keep; Ya Hua
Journal:  Transl Stroke Res       Date:  2014-06-17       Impact factor: 6.829

4.  Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats.

Authors:  Pramod K Dash; Sara A Orsi; Min Zhang; Raymond J Grill; Shibani Pati; Jing Zhao; Anthony N Moore
Journal:  PLoS One       Date:  2010-06-30       Impact factor: 3.240

5.  Increased expression of ferritin in cerebral cortex after human traumatic brain injury.

Authors:  Huan-Dong Liu; Wei Li; Zhen-Rui Chen; Meng-Liang Zhou; Zong Zhuang; Ding-Ding Zhang; Lin Zhu; Chun-Hua Hang
Journal:  Neurol Sci       Date:  2012-10-19       Impact factor: 3.307

6.  Post-acute pathological changes in the thalamus and internal capsule in aged mice following controlled cortical impact injury: a magnetic resonance imaging, iron histochemical, and glial immunohistochemical study.

Authors:  Gregory Onyszchuk; Steven M LeVine; William M Brooks; Nancy E J Berman
Journal:  Neurosci Lett       Date:  2009-01-23       Impact factor: 3.046

Review 7.  Organotypic Hippocampal Slices as Models for Stroke and Traumatic Brain Injury.

Authors:  Qian Li; Xiaoning Han; Jian Wang
Journal:  Mol Neurobiol       Date:  2015-07-30       Impact factor: 5.590

Review 8.  Iron in chronic brain disorders: imaging and neurotherapeutic implications.

Authors:  James Stankiewicz; S Scott Panter; Mohit Neema; Ashish Arora; Courtney E Batt; Rohit Bakshi
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

9.  Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke.

Authors:  Leah R Hanson; Annina Roeytenberg; Paula M Martinez; Valerie G Coppes; Donald C Sweet; Reshma J Rao; Dianne L Marti; John D Hoekman; Rachel B Matthews; William H Frey; S Scott Panter
Journal:  J Pharmacol Exp Ther       Date:  2009-06-09       Impact factor: 4.030

Review 10.  Traumatic injury to the immature brain: inflammation, oxidative injury, and iron-mediated damage as potential therapeutic targets.

Authors:  Mathew B Potts; Seong-Eun Koh; William D Whetstone; Breset A Walker; Tomoko Yoneyama; Catherine P Claus; Hovhannes M Manvelyan; Linda J Noble-Haeusslein
Journal:  NeuroRx       Date:  2006-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.